CompletedN/AOther

Benefits of Opioid Free Anesthesia on Morphine Consumption in Gastric Bypass

Sponsored by matthieu clanet

NCT ID
NCT05004519
Target Enrollment
183 participants
Start Date
2021-10-05
Est. Completion
2022-10-15

About This Study

Opioid free anesthesia is a recent anesthesia technique with the aim to avoid peroperative use of morphinics to allow a diminution of secondary morphinics effects in the postoperative period. There is no robust data on the real benefits of such procedures. Obese patients are particular at risk of secondary effects of opioids. The aim of our study is to compare opioid free anesthesia to multimodal anesthesia on postoperative morphine consumption after a laparoscopic gastric bypass.

Conditions Studied

Analgesics, Opioid

Interventions

  • Dexmedetomidine Injection [Precedex]
  • Remifentanil

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* American Society of anesthesia score (ASA) 2-3
* Scheduled for a laparoscopic gastric bypass surgery

Exclusion Criteria:

* Patient refusal
* Medical diseases: Cardiac arrhythmia like atrioventricular block 2nd or 3rd degree, pacemaker, arterial hypotension, severe bradycardia, cerebrovascular pathology, renal and/or hepatic insufficiency
* Previous bariatric surgery
* Allergy to any medication used during the surgery

Study Locations (1)

CHIREC Delta Hospital
Brussels, Belgium

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source